Amphastar Pharmaceuticals (AMPH) PT Lowered to $30 at Needham Feb 27, 2026 07:25AM
Amphastar Pharma (AMPH) Misses Q4 EPS by 20c Feb 26, 2026 04:53PM
Amphastar receives FDA approval for generic respiratory drug Feb 24, 2026 06:00AM
Amphastar Announces FDA Approval for Ipratropium Bromide HFA Feb 24, 2026 06:00AM
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026 Feb 20, 2026 06:00AM
View Older Stories

Jan 12, 2026 06:00AM Amphastar licenses synthetic hormone compound for $91 million deal
Jan 12, 2026 06:00AM Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
Jan 7, 2026 06:00AM Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference
Dec 15, 2025 06:01AM Amphastar receives FDA approval for generic teriparatide injection
Dec 15, 2025 06:00AM Amphastar Announces FDA Approval for Teriparatide Injection
Nov 24, 2025 06:00AM Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference
Nov 12, 2025 06:00AM Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Nov 6, 2025 04:05PM Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025
Oct 27, 2025 06:00AM Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025
Sep 18, 2025 04:55PM Amphastar enters $2.8 million research agreement with Hanxin
Aug 28, 2025 06:00AM Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference
Aug 12, 2025 07:08AM Needham Upgrades Amphastar Pharmaceuticals (AMPH) to Buy
Aug 12, 2025 06:01AM Amphastar licenses three peptide drugs from Nanjing Anji for $453 million
Aug 12, 2025 06:00AM Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.
Aug 11, 2025 06:00AM Amphastar receives FDA approval for generic iron sucrose injection
Aug 11, 2025 06:00AM Amphastar Announces FDA Approval for Iron Sucrose Injection, USP
Aug 8, 2025 06:43AM Amphastar Pharmaceuticals (AMPH) PT Lowered to $25 at Piper Sandler
Aug 7, 2025 04:23PM Amphastar Pharma (AMPH) Tops Q2 EPS by 11c
Aug 7, 2025 04:05PM Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025
Jul 29, 2025 06:00AM Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025
Jul 14, 2025 04:07PM Amphastar plans to quadruple manufacturing capacity at California facility
Jul 14, 2025 04:05PM Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters
May 22, 2025 06:00AM Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
May 12, 2025 02:52AM JPMorgan Downgrades Amphastar Pharmaceuticals (AMPH) to Neutral
May 9, 2025 06:00AM Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference
May 8, 2025 01:42AM Amphastar Pharma (AMPH) Tops Q1 EPS by 5c
May 7, 2025 04:05PM Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
Apr 30, 2025 06:00AM Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025
Apr 3, 2025 06:00AM Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
Mar 28, 2025 06:00AM International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award
Mar 21, 2025 10:39AM Amphastar Pharmaceuticals (AMPH) PT Lowered to $32 at Piper Sandler; 'A Tough 2025 Ahead'
Mar 5, 2025 06:00AM Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference
Feb 27, 2025 04:27PM Amphastar Pharma (AMPH) Misses Q4 EPS by 5c
Feb 27, 2025 04:05PM Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024
Feb 20, 2025 04:05PM Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025
Feb 4, 2025 03:46AM Piper Sandler Downgrades Amphastar Pharmaceuticals (AMPH) to Neutral
Jan 8, 2025 06:00AM Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Nov 26, 2024 04:05PM Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference
Nov 22, 2024 06:10AM Wells Fargo Starts Amphastar Pharmaceuticals (AMPH) at Overweight
Nov 13, 2024 04:05PM Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Nov 8, 2024 01:26AM Amphastar Pharma (AMPH) Misses Q3 EPS by 4c
Nov 6, 2024 04:05PM Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024
Oct 29, 2024 06:00AM Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024
Aug 28, 2024 04:10PM Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
Aug 12, 2024 11:12AM Amphastar Pharmaceuticals (AMPH) PT Lowered to $55 at Jefferies
Aug 8, 2024 08:06AM Amphastar Pharmaceuticals (AMPH) PT Lowered to $66 at Piper Sandler
Aug 7, 2024 04:05PM Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024
Jul 31, 2024 04:05PM Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024
Jul 21, 2024 06:00AM 10 policies if Trump wins and stock implications: Jefferies
Jun 27, 2024 09:29AM Piper Sandler Reiterates Overweight Rating on Amphastar Pharmaceuticals (AMPH)
View Older Stories